Interaction Landscape of Inherited Polymorphisms with Somatic Events in Cancer.
暂无分享,去创建一个
Trey Ideker | Hannah Carter | Christopher M. DeBoever | Kathleen M Fisch | Eric L Van Nostrand | Gene W Yeo | Gene W. Yeo | J Silvio Gutkind | Jason F Kreisberg | James D. Jensen | Scott M Lippman | Andrew M. Gross | T. Ideker | S. Lippman | H. Carter | C. DeBoever | Matan Hofree | Eric L. Van Nostrand | J. Kreisberg | J. S. Gutkind | K. Fisch | Yan Song | Rachel Marty | Matan Hofree | Xingyu Wu | Emily C. Wheeler | Andrew M Gross | James Jensen | Yan Song | Christopher DeBoever | Rachel Marty | Xingyu Wu | Emily Wheeler | J. Gutkind
[1] Abdullahi Umar Ibrahim,et al. Genome Engineering Using the CRISPR Cas9 System , 2019 .
[2] Alan M. Kwong,et al. Next-generation genotype imputation service and methods , 2016, Nature Genetics.
[3] P. Guénel,et al. Fine‐mapping of two differentiated thyroid carcinoma susceptibility loci at 9q22.33 and 14q13.3 detects novel candidate functional SNPs in Europeans from metropolitan France and Melanesians from New Caledonia , 2016, International journal of cancer.
[4] Sourav Bandyopadhyay,et al. Challenges in identifying cancer genes by analysis of exome sequencing data , 2016, Nature Communications.
[5] M. Nakashima,et al. Targeted Foxe1 Overexpression in Mouse Thyroid Causes the Development of Multinodular Goiter But Does Not Promote Carcinogenesis. , 2016, Endocrinology.
[6] Li-guo Qi,et al. Epigenetic down-regulated DDX10 promotes cell proliferation through Akt/NF-κB pathway in ovarian cancer. , 2016, Biochemical and biophysical research communications.
[7] Li Ding,et al. Patterns and functional implications of rare germline variants across 12 cancer types , 2015, Nature Communications.
[8] M. Khoury,et al. Targeted Cancer Screening in Average-Risk Individuals. , 2015, American journal of preventive medicine.
[9] V. Nenasheva,et al. Enhanced expression of trim14 gene suppressed Sindbis virus reproduction and modulated the transcription of a large number of genes of innate immunity , 2015, Immunologic research.
[10] Qian S. Zhang,et al. Genome-wide haplotypic testing in a Finnish cohort identifies a novel association with low-density lipoprotein cholesterol , 2014, European Journal of Human Genetics.
[11] Sandya Liyanarachchi,et al. Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer , 2015, Proceedings of the National Academy of Sciences.
[12] Dennis Carson,et al. Transcriptome Sequencing Reveals Potential Mechanism of Cryptic 3’ Splice Site Selection in SF3B1-mutated Cancers , 2015, PLoS Comput. Biol..
[13] Emily Kang,et al. Cancer-Associated Protein Kinase C Mutations Reveal Kinase’s Role as Tumor Suppressor , 2015, Cell.
[14] Feng Zhang,et al. Genome engineering using CRISPR-Cas9 system. , 2015, Methods in molecular biology.
[15] A. Shoushtari,et al. GNAQ and GNA11 mutations in uveal melanoma , 2014, Melanoma research.
[16] A. Spurdle,et al. Most common 'sporadic' cancers have a significant germline genetic component. , 2014, Human molecular genetics.
[17] Qing-Rong Chen,et al. Systematic Genetic Analysis Identifies Cis-eQTL Target Genes Associated with Glioblastoma Patient Survival , 2014, PloS one.
[18] Rocky Cipriano,et al. Conserved Oncogenic Behavior of the FAM83 Family Regulates MAPK Signaling in Human Cancer , 2014, Molecular Cancer Research.
[19] T. Meehan,et al. An atlas of active enhancers across human cell types and tissues , 2014, Nature.
[20] Muin J Khoury,et al. A systematic review of cancer GWAS and candidate gene meta-analyses reveals limited overlap but similar effect sizes , 2013, European Journal of Human Genetics.
[21] Benjamin J. Raphael,et al. Integrated Analysis of Germline and Somatic Variants in Ovarian Cancer , 2014, Nature Communications.
[22] Peggy Hall,et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations , 2013, Nucleic Acids Res..
[23] Chris Sander,et al. Emerging landscape of oncogenic signatures across human cancers , 2013, Nature Genetics.
[24] Brendan J. Frey,et al. A compendium of RNA-binding motifs for decoding gene regulation , 2013, Nature.
[25] J. Gutkind,et al. Exploiting the head and neck cancer oncogenome: widespread PI3K-mTOR pathway alterations and novel molecular targets. , 2013, Cancer discovery.
[26] Steven J. M. Jones,et al. Integrated genomic characterization of endometrial carcinoma , 2013, Nature.
[27] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[28] A. Sivachenko,et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.
[29] A. McKenna,et al. Integrative eQTL-Based Analyses Reveal the Biology of Breast Cancer Risk Loci , 2013, Cell.
[30] David Haussler,et al. The UCSC genome browser and associated tools , 2012, Briefings Bioinform..
[31] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .
[32] A. Mannermaa,et al. Hyaluronan synthases (HAS1–3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival , 2013, Breast Cancer Research and Treatment.
[33] A. Gonzalez-Perez,et al. Functional impact bias reveals cancer drivers , 2012, Nucleic acids research.
[34] A. Sivachenko,et al. Sequence analysis of mutations and translocations across breast cancer subtypes , 2012, Nature.
[35] Joaquín Dopazo,et al. SNPeffect 4.0: on-line prediction of molecular and structural effects of protein-coding variants , 2011, Nucleic Acids Res..
[36] C. Sander,et al. Predicting the functional impact of protein mutations: application to cancer genomics , 2011, Nucleic acids research.
[37] C. Carlson,et al. Principles for the post-GWAS functional characterization of cancer risk loci , 2011, Nature Genetics.
[38] G. Getz,et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.
[39] M. Ratain,et al. Functional EGFR germline polymorphisms may confer risk for EGFR somatic mutations in non-small cell lung cancer, with a predominant effect on exon 19 microdeletions. , 2011, Cancer research.
[40] R. Houlston,et al. Genome-wide association studies for detecting cancer susceptibility. , 2011, British medical bulletin.
[41] C. Glass,et al. Coronin2A mediates actin-dependent de-repression of inflammatory response genes , 2011, Nature.
[42] Soichiro Saito,et al. High frequency of common DNA copy number abnormalities detected by bacterial artificial chromosome array comparative genomic hybridization in 24 breast cancer cell lines , 2009, Human Cell.
[43] R. Cardiff,et al. ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2. , 2010, Cancer research.
[44] Sharon R Grossman,et al. Integrating common and rare genetic variation in diverse human populations , 2010, Nature.
[45] Michael Boehnke,et al. LocusZoom: regional visualization of genome-wide association scan results , 2010, Bioinform..
[46] Dan L Nicolae,et al. Spoiling the whole bunch: quality control aimed at preserving the integrity of high-throughput genotyping. , 2010, American journal of human genetics.
[47] Douglas F Easton,et al. Genome-wide association studies in common cancers--what have we learnt? , 2010, Current opinion in genetics & development.
[48] K. Luger,et al. The histone chaperone Nap1 promotes nucleosome assembly by eliminating nonnucleosomal histone DNA interactions. , 2010, Molecular cell.
[49] Gary D Bader,et al. International network of cancer genome projects , 2010, Nature.
[50] John P A Ioannidis,et al. Beyond genome-wide association studies: genetic heterogeneity and individual predisposition to cancer. , 2010, Trends in genetics : TIG.
[51] klaguia. International Network of Cancer Genome Projects , 2010 .
[52] Hyonho Chun,et al. Genome-wide association studies using single-nucleotide polymorphisms versus haplotypes: an empirical comparison with data from the North American Rheumatoid Arthritis Consortium , 2009, BMC proceedings.
[53] Steven J. M. Jones,et al. Circos: an information aesthetic for comparative genomics. , 2009, Genome research.
[54] M. Pelizzo,et al. The Variant rs1867277 in FOXE1 Gene Confers Thyroid Cancer Susceptibility through the Recruitment of USF1/USF2 Transcription Factors , 2009, PLoS genetics.
[55] R. Klopfleisch,et al. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas. , 2009, Journal of comparative pathology.
[56] R. Shaw,et al. The LKB1–AMPK pathway: metabolism and growth control in tumour suppression , 2009, Nature Reviews Cancer.
[57] M. Stratton,et al. The cancer genome , 2009, Nature.
[58] Kari Stefansson,et al. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations , 2009, Nature Genetics.
[59] P. Campbell. Somatic and germline genetics at the JAK2 locus , 2009, Nature Genetics.
[60] Andrew D. Johnson,et al. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap , 2008, Bioinform..
[61] Joshua M. Korn,et al. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs , 2008, Nature Genetics.
[62] Joseph T. Glessner,et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.
[63] B. Browning,et al. Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. , 2007, American journal of human genetics.
[64] C. Eng,et al. Hamartomatous polyposis syndromes , 2007, Nature Clinical Practice Gastroenterology &Hepatology.
[65] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[66] Francis S. Collins,et al. Mapping the cancer genome , 2007 .
[67] Francis S Collins,et al. Mapping the cancer genome. Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies. , 2007, Scientific American.
[68] Jeffrey E. Barrick,et al. The power of riboswitches. , 2007, Scientific American.
[69] Georg Heinze,et al. A comparative investigation of methods for logistic regression with separated or nearly separated data , 2006, Statistics in medicine.
[70] Nazneen Rahman,et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles , 2006, Nature Genetics.
[71] S. Gabriel,et al. Efficiency and power in genetic association studies , 2005, Nature Genetics.
[72] Charis Eng,et al. Highly penetrant hereditary cancer syndromes , 2004, Oncogene.
[73] C. Downes,et al. PTEN function: how normal cells control it and tumour cells lose it. , 2004, The Biochemical journal.
[74] P. Donnelly,et al. The effects of human population structure on large genetic association studies , 2004, Nature Genetics.
[75] P. Sham,et al. Haplotype Association Analysis of Discrete and Continuous Traits Using Mixture of Regression Models , 2004, Behavior genetics.
[76] Terrence S. Furey,et al. The UCSC Table Browser data retrieval tool , 2004, Nucleic Acids Res..
[77] Pak Chung Sham,et al. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits , 2003, Bioinform..
[78] K. Czene,et al. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family‐cancer database , 2002, International journal of cancer.
[79] J. Kaprio,et al. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.
[80] B. Melichar,et al. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA‐4 on malignant ascites CD3+ tumour‐infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis , 2000, Clinical and experimental immunology.